Naltrexone Hydrochloride
Product Images NDC 76519-1160

2 FDA label images from H.j. Harkins Company Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Naltrexone Hydrochloride (NDC 76519-1160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

76519 1160.jpg (76519 1160)

76519 1160.jpg (76519 1160)
NALTREXONE HYDROCHLORIDE 50MG tablet label showing prescription drug warnings, NDC 76519-1160-XX, lot number P0300129, and manufacturer TAGI PHARM 51224-0206-50. Contains multiple repeated sections with drug name, NDC, expiration date 04/30/19, lot, and manufacturer NDC. Includes instruction 'Take as directed by your Physician' and barcodes. Labeler is H.J. Harkins Company Inc.*
FDA Label Image

Naltrexone (Naltrexone)

Naltrexone (Naltrexone)
Chemical structure of naltrexone hydrochloride. The diagram shows the molecular arrangement of naltrexone with its hydroxyl, ketone, and amine groups, including the hydrochloride salt component (HCl).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.